Shear Stress-sensitive Carriers for Localized Drug Delivery
Related Experiment Video
Updated: Mar 18, 2026

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
Published on: November 7, 2013
Yu Xia, Chun-Yang Shi1, Wei Xiong
1Department of Pharmacy, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 430000.
Insights
Vascular stenosis elevates shear stress, activating platelets and inspiring shear-activated drug delivery. This novel approach targets constricted vessels, offering new treatments for cardiovascular diseases.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Drug Delivery Systems
Background:
- Vascular stenosis, a common feature of cardiovascular diseases, significantly alters blood flow dynamics.
- Elevated hemodynamic shear stress at stenotic sites triggers platelet activation, adhesion, and aggregation.
- Platelet response to high shear stress presents a therapeutic target for localized drug delivery.
Purpose of the Study:
- To review the role of hemodynamic shear stress in vascular stenosis.
- To explore shear stress-activated drug delivery systems as a novel therapeutic strategy.
- To discuss the potential clinical applications of shear-sensitive drug carriers.
Main Methods:
- Review of literature on hemodynamic shear stress in physiological and pathological conditions.
- Summary of shear stress-sensitive drug carriers (liposomes, gels, emulsions).
- Analysis of factors influencing the mechanical properties of these carriers.
- Discussion of clinical applications and future prospects.
Main Results:
- Shear stress is significantly elevated at stenotic sites, leading to platelet activation.
- Various carriers (liposomes, aggregations, gels, emulsions) exhibit shear stress sensitivity.
- Understanding shear stress-dependent carrier behavior is crucial for targeted delivery.
Conclusions:
- Shear stress-activated drug delivery offers a promising targeted approach for cardiovascular diseases.
- Further research into shear stress-sensitive carriers can advance clinical applications.
- This strategy holds potential for future targeted therapies in vascular conditions.
Abstract:
Stenosis of the critical blood vessels, which occurs in a variety of cardiovascular and cerebrovascular diseases, is one of leading causes of death in the world. Vascular stenosis will significantly alter the hemodynamic features in the vessel. Hemodynamic shear stress, one of the most important physical parameters of blood flow, will be dramatically elevated at the stenotic site. When platelets flow through the constricted site, they will sense these abnormally high shear stresses, and then respond by activating, sticking to the vascular wall, and aggregating at these sites. The shear-dependent platelet activation inspired a novel targeting platform-shear stress activated drug targeting delivery. The shear-activated drug delivery systems preferentially release their content under elevated shear stress, providing a novel approach to cure various diseases, in particular, cardiovascular diseases. In this review, we, on one hand, introduced the features of hemodynamic shear stress under both physiological and pathological conditions. On the other hand, we summarized the carriers displaying sensitivity to shear stress, such as liposomes, aggregations, gels, emulsions, in addition to the factors affecting the mechanical properties of them. Lastly, the clinical applications and prospects of this novel drug targeting strategy were discussed. It is hoped that, with a better understanding of shear stress-sensitive carriers and their targeted principle, a novel targeted drug delivery strategy will be one day applied in the clinics of the future.
More Related Videos
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Modified-Release Drug Delivery Systems: Stimuli-Activated
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Modified-Release Drug Delivery Systems: Classification
Transdermal Drug Delivery Systems

